The Food and Drug Administration (FDA) has approved Isturisa ® (osilodrostat) for the treatment of endogenous hypercortisolemia in adults with Cushing syndrome for whom surgery is not an option or has ...

Corcept sees 40% growth in 2025 revenue with promising trials, expanded patient base, and strong projections. Read my ...

Still, doctors say there is a need for more awareness of a rare and potentially life-threatening condition involving cortisol, known as Cushing syndrome. In a new editorial from MerckManuals.com ...

Cushing’s syndrome survivor and public health advocate ... Fari called on President Bola Ahmed Tinubu’s administration to invest in rare disease research, strengthen advocacy, and train ...

In his tear-jerking memoir, Surviving Cushing's Disease: A Young Man's Journey, Chuck Knueve recounts the gritty, emotional story of his son's battle to be diagnosed with Cushing's disease ...

Previously, the treatment had been indicated for Cushing disease, a subtype of Cushing syndrome. Isturisa is a cortisol synthesis inhibitor. By blocking 11-beta-hydroxylase, the enzyme responsible ...